Furthermore, KTN1-AS1 increases the viability and invasive ability of glioma cells in vitro and in vivo through the KTN1-AS1/miR-505-3p pathway and promotes tumor growth of HCC via the miR-23c/ERBB2IP axis [64, 65]. The gene discussed is KTN1; the disease is glioma.